Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry
|
October 18, 2019
A structure-based approach towards the identification of novel antichagasic compounds: <i>Trypanosoma cruzi</i> carbonic anhydrase inhibitors
Manuel A Llanos, María L Sbaraglini, María L Villalba, et al.
Mini Reviews in Medicinal Chemistry
|
October 15, 2016
Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy
Manuel Couyoupetrou, Melisa E Gantner, Mauricio E Di Ianni, et al.
Journal of Chemical Information and Modeling
|
November 2, 2023
A Combined Ligand- and Structure-Based Virtual Screening To Identify Novel NaV1.2 Blockers: In Vitro Patch Clamp Validation and In Vivo Anticonvulsant Activity
Manuel A Llanos, Nicolás Enrique, Vega Esteban-López, et al.
Frontiers in Molecular Biosciences
|
January 22, 2026
Advancing <i>Trypanosoma cruzi</i> N-myristoyltransferase as a drug target for Chagas disease through <i>in silico</i> discovery and biochemical evaluation
Diana González García, Angel Torres, Alan Talevi, et al.
Pharmaceutics
|
December 31, 2025
Application of Data-Centric Supervised Machine Learning to Predict Phenotypic Activity Against Clinically Relevant Stages of <i>Trypanosoma cruzi</i>
Nicolás Pérez-Mauad, Lucas N Alberca, Alejandra C Schoijet, et al.
Journal of Computer-Aided Molecular Design
|
December 9, 2022
A combined ligand and target-based virtual screening strategy to repurpose drugs as putrescine uptake inhibitors with trypanocidal activity
Manuel A Llanos, Lucas N Alberca, María D Ruiz, et al.
Journal of Neurotrauma
|
April 17, 2025
Mitigation of Acute Seizures and Neuropathology after Traumatic Brain Injury by Structure-Based Discovery-Identified Drugs
Natallie Kajevu, Ivette Banuelos, Pedro Andrade, et al.
Frontiers in Chemistry
|
September 5, 2022
Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to <i>In Vivo</i> Evaluation
Sebastian Scioli-Montoto, Maria Laura Sbaraglini, Jose Sebastian Cisneros, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 7, 2020
Machine Learning in Drug Discovery and Development Part 1: A Primer
Alan Talevi, Juan Francisco Morales, Gregory Hather, et al.
European Journal of Medicinal Chemistry
|
February 24, 2015
Computer-guided drug repurposing: identification of trypanocidal activity of clofazimine, benidipine and saquinavir
Carolina L Bellera, Darío E Balcazar, M Cristina Vanrell, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Journal of Enzyme Inhibition and Medicinal Chemistry
|
October 18, 2019
A structure-based approach towards the identification of novel antichagasic compounds: <i>Trypanosoma cruzi</i> carbonic anhydrase inhibitors
Manuel A Llanos, María L Sbaraglini, María L Villalba, et al.
Mini Reviews in Medicinal Chemistry
|
October 15, 2016
Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy
Manuel Couyoupetrou, Melisa E Gantner, Mauricio E Di Ianni, et al.
Journal of Chemical Information and Modeling
|
November 2, 2023
A Combined Ligand- and Structure-Based Virtual Screening To Identify Novel NaV1.2 Blockers: In Vitro Patch Clamp Validation and In Vivo Anticonvulsant Activity
Manuel A Llanos, Nicolás Enrique, Vega Esteban-López, et al.
Frontiers in Molecular Biosciences
|
January 22, 2026
Advancing <i>Trypanosoma cruzi</i> N-myristoyltransferase as a drug target for Chagas disease through <i>in silico</i> discovery and biochemical evaluation
Diana González García, Angel Torres, Alan Talevi, et al.
Pharmaceutics
|
December 31, 2025
Application of Data-Centric Supervised Machine Learning to Predict Phenotypic Activity Against Clinically Relevant Stages of <i>Trypanosoma cruzi</i>
Nicolás Pérez-Mauad, Lucas N Alberca, Alejandra C Schoijet, et al.
Journal of Computer-Aided Molecular Design
|
December 9, 2022
A combined ligand and target-based virtual screening strategy to repurpose drugs as putrescine uptake inhibitors with trypanocidal activity
Manuel A Llanos, Lucas N Alberca, María D Ruiz, et al.
Journal of Neurotrauma
|
April 17, 2025
Mitigation of Acute Seizures and Neuropathology after Traumatic Brain Injury by Structure-Based Discovery-Identified Drugs
Natallie Kajevu, Ivette Banuelos, Pedro Andrade, et al.
Frontiers in Chemistry
|
September 5, 2022
Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to <i>In Vivo</i> Evaluation
Sebastian Scioli-Montoto, Maria Laura Sbaraglini, Jose Sebastian Cisneros, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 7, 2020
Machine Learning in Drug Discovery and Development Part 1: A Primer
Alan Talevi, Juan Francisco Morales, Gregory Hather, et al.
European Journal of Medicinal Chemistry
|
February 24, 2015
Computer-guided drug repurposing: identification of trypanocidal activity of clofazimine, benidipine and saquinavir
Carolina L Bellera, Darío E Balcazar, M Cristina Vanrell, et al.
Page
of 9